FAMILY STUDIES OF THE GENETICS OF ANKYLOSING SPONDYLITIS

强直性脊柱炎遗传学的家庭研究

基本信息

项目摘要

Although HLA-B27 is regarded as an essential feature for the development of ankylosing spondylitis (AS, recent studies have implicated other genes and chromosomal regions, both inside and outside the major histocompatibility complex (MHC), in the pathogenesis of the disorder. The entire MHC contribution has been calculated at only 31 percent. Linkage analysis of sib pairs from the United Kingdom has shown eight chromosomal regions, including the MHC, to have moderate evidence of linkage to AS. However, many genes are contained in these regions, and which are the actual disease susceptibility genes within these regions has not been established. Thus, the specific aims of this proposal are: 1) to establish a consortium of investigators with a recent record of clinical or genetic research in AS (and hence established patient cohorts) based at 10 academic medical centers throughout North America (the North American Spondylitis Consortium-NASC) in order to identify from their cohorts families with at least two siblings fulfilling the modified New York criteria for AS; 2) from the membership of the Spondylitis Association of America (SAA), to identify similarly affected families and verify the diagnoses in both groups by questionnaire, medical record review and pelvic radiographs; 3) to collect 50 ml of blood from affected and unaffected sib pairs and, when available, both their parents in order to establish a bank of sera, genomic DNA and frozen lymphocytes from these 400 families; 4) to characterize the MHC contribution to predisposition to AS by DNA typing for HLA-B27 alleles, B60 and HLA-DRB1, DQA1 and DQB1 alleles; 5) to conduct a genome wide search using closely spaced microsatellite markers in sib pairs concordant and discordant for AS in the 400 Caucasian families; 6) to conduct microsatellite polymorphism analyses of non-MHC genes using multipoint analyses for fine mapping studies of genes linked to AS using transmission disequilibrium testing (TDT); and finally, 7) to study sequence variation of three to four candidate genes in 25 AS patients and 25 controls to identify the mutations an disease-relevant polymorphisms involved in AS.
虽然人类白细胞抗原B27被认为是强直性脊柱炎(AS)发生发展的基本特征,但最近的研究表明,主要组织相容性复合体(MHC)内外的其他基因和染色体区域也参与了AS的发病机制。整个MHC的贡献只有31%。对来自英国的同胞对的连锁分析表明,包括MHC在内的8个染色体区域有中度连锁的证据。然而,许多基因都包含在这些区域中,这些区域中哪些是实际的疾病易感基因尚未确定。因此,这项建议的具体目标是:1)建立一个最近有AS临床或基因研究记录的研究人员联盟(因此建立了患者队列),总部设在北美的10个学术医疗中心(北美脊柱炎协会-NASC),以便从他们的队列中确定至少有两个兄弟姐妹符合修改后的AS纽约标准的家庭;2)从美国脊柱炎协会(SAA)的成员中,确定受类似影响的家庭,并通过问卷、病历回顾和骨盆X光检查来核实两组中的诊断;3)从受影响和未受影响的同胞对及其父母(如有的话)采集50毫升血液,以建立这400个家庭的血清、基因组DNA和冰冻淋巴细胞库;4)通过对人类白细胞抗原-B27等位基因、B60和人类白细胞抗原DRB1、DQA1和DQB1等位基因的DNA分型,确定MHC对AS易感性的贡献;5)在400个高加索家庭中,使用紧密分布的微卫星标记,对符合和不一致的同胞对AS进行全基因组搜索;6)使用多点分析对非MHC基因进行微卫星分析,以利用传递不平衡检验(TDT)对与AS有关的基因进行精细定位研究;7)研究25例AS患者和25例对照中3~4个候选基因的序列变异,以确定AS相关疾病相关基因的突变。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN Duffin REVEILLE其他文献

JOHN Duffin REVEILLE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN Duffin REVEILLE', 18)}}的其他基金

The Genetic Basis of AS Susceptibility
AS 易感性的遗传基础
  • 批准号:
    7504076
  • 财政年份:
    2007
  • 资助金额:
    $ 96.37万
  • 项目类别:
Defining the Spectrum of Spondyloarthritis in Family Members of Parents with ....
定义父母家庭成员的脊柱关节炎谱系......
  • 批准号:
    7504078
  • 财政年份:
    2007
  • 资助金额:
    $ 96.37万
  • 项目类别:
Pre-and Postdoctoral Training in the Rheumatic Diseases
风湿病博士前和博士后培训
  • 批准号:
    7457844
  • 财政年份:
    2007
  • 资助金额:
    $ 96.37万
  • 项目类别:
Pre-and Postdoctoral Training in the Rheumatic Diseases
风湿病博士前和博士后培训
  • 批准号:
    7880189
  • 财政年份:
    2007
  • 资助金额:
    $ 96.37万
  • 项目类别:
Pre-and Postdoctoral Training in the Rheumatic Diseases
风湿病博士前和博士后培训
  • 批准号:
    8103955
  • 财政年份:
    2007
  • 资助金额:
    $ 96.37万
  • 项目类别:
Pre-and Postdoctoral Training in the Rheumatic Diseases
风湿病博士前和博士后培训
  • 批准号:
    7643481
  • 财政年份:
    2007
  • 资助金额:
    $ 96.37万
  • 项目类别:
Pre-and Postdoctoral Training in the Rheumatic Diseases
风湿病博士前和博士后培训
  • 批准号:
    7232875
  • 财政年份:
    2007
  • 资助金额:
    $ 96.37万
  • 项目类别:
Administrative/Sample and Data Management Core
管理/样本和数据管理核心
  • 批准号:
    7504074
  • 财政年份:
    2007
  • 资助金额:
    $ 96.37万
  • 项目类别:
A Comprehensive Model of Severity in Outcomes in Ankylosing Spondylitis
强直性脊柱炎结果严重程度的综合模型
  • 批准号:
    7504077
  • 财政年份:
    2007
  • 资助金额:
    $ 96.37万
  • 项目类别:
Spondyloarthritis 2006; The Unmet Needs
脊柱关节炎2006;
  • 批准号:
    7113319
  • 财政年份:
    2006
  • 资助金额:
    $ 96.37万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 96.37万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 96.37万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 96.37万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 96.37万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 96.37万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 96.37万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 96.37万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 96.37万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 96.37万
  • 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
  • 批准号:
    10762827
  • 财政年份:
    2023
  • 资助金额:
    $ 96.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了